Guangxu Zhang

Key Laboratory Of Medical Molecular Virology
Shanghai, 671003, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Mechanisms Underlying the Induction of Immunological Imprinting by RNA Viruses and Intervention Strategies.

Mechanisms Underlying the Induction of Immunological Imprinting by RNA Viruses and Intervention Strategies.

Journal: Viruses

Published: June 01, 2026

A VLP-based mRNA vaccine elicits potent humoral and cellular immunity against Oropouche virus.

A VLP-based mRNA vaccine elicits potent humoral and cellular immunity against Oropouche virus.

Journal: mBio

Published: January 12, 2026

A highly potent, stable, and safe dePEGylated lipopeptide against Nipah virus and related henipaviruses.

A highly potent, stable, and safe dePEGylated lipopeptide against Nipah virus and related henipaviruses.

Journal: Emerging microbes & infections

Published: December 29, 2025

Precision-engineered STING agonist nanoparticles enable coordinated mucosal-systemic immunity for durable pan-β-coronavirus protection.

Precision-engineered STING agonist nanoparticles enable coordinated mucosal-systemic immunity for durable pan-β-coronavirus protection.

Journal: Nature nanotechnology

Published: August 05, 2025

Genomic signatures and host adaptation of H5N1 clade 2.3.4.4b: A call for global surveillance and multi-target antiviral strategies.

Genomic signatures and host adaptation of H5N1 clade 2.3.4.4b: A call for global surveillance and multi-target antiviral strategies.

Journal: Current research in microbial sciences

Published: April 03, 2025

Leveraged Vaccination to Alleviate Original Antigenic Sin for Enhancing Broad-Neutralizing Antibody Response against SARS-CoV-2 Omicron Subvariants.

Leveraged Vaccination to Alleviate Original Antigenic Sin for Enhancing Broad-Neutralizing Antibody Response against SARS-CoV-2 Omicron Subvariants.

Journal: MedComm

Published: September 18, 2024

Alpaca-derived nanobody targeting the hydrophobic pocket of the HIV-1 gp41 NHR broadly neutralizes HIV-1 by blocking six-helix bundle formation.

Alpaca-derived nanobody targeting the hydrophobic pocket of the HIV-1 gp41 NHR broadly neutralizes HIV-1 by blocking six-helix bundle formation.

Journal: Current research in microbial sciences

Published: August 23, 2024

Early fusion intermediate of ACE2-using coronavirus spike acting as an antiviral target.

Early fusion intermediate of ACE2-using coronavirus spike acting as an antiviral target.

Journal: Cell

Published: April 30, 2024

Clinical development of antivirals against SARS-CoV-2 and its variants.

Clinical development of antivirals against SARS-CoV-2 and its variants.

Journal: Current research in microbial sciences

Published: December 27, 2023

Neutralization of SARS-CoV-2 BA.2.86 and JN.1 by CF501 adjuvant-enhanced immune responses targeting the conserved epitopes in ancestral RBD.

Neutralization of SARS-CoV-2 BA.2.86 and JN.1 by CF501 adjuvant-enhanced immune responses targeting the conserved epitopes in ancestral RBD.

Journal: Cell reports. Medicine

Published: November 01, 2023

A pan-sarbecovirus vaccine based on RBD of SARS-CoV-2 original strain elicits potent neutralizing antibodies against XBB in non-human primates.

A pan-sarbecovirus vaccine based on RBD of SARS-CoV-2 original strain elicits potent neutralizing antibodies against XBB in non-human primates.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: March 10, 2023

Development of variant-proof severe acute respiratory syndrome coronavirus 2, pan-sarbecovirus, and pan-β-coronavirus vaccines.

Development of variant-proof severe acute respiratory syndrome coronavirus 2, pan-sarbecovirus, and pan-β-coronavirus vaccines.

Journal: Journal of medical virology

Published: August 24, 2022

Showing 1-12 of 14

Last Updated: 09/26/2026